rss
Br J Ophthalmol 89:266-268 doi:10.1136/bjo.2004.049841
  • Clinical science
    • Scientific reports

A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients

Table 4

 Time course changes in corneal sensitivity

CT-112 group (g/mm2) Placebo group (g/mm2) p Value
*Mann-Whitney U test.
Pretreatment 1.00 (0.19) 0.99 (0.08) 0.91*
4 weeks 0.96 (0) 0.96 (0) 0.99*
8 weeks 0.97 (0.04) 0.97 (0.04) 0.94*

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.